Jun 26, 2025, 12:58
Welcoming Opposition to ISTH 2025: EHC Highlights the Crucial Role of Modern Treatments in Hemophilia Management
The European Haemophilia Consortium shared a post on X:
”The EHC attended ISTH 2025, where Maria Elisa Mancuso & Mark Skinner presented manuscripts we co-authored opposing the ISTH Guidelines. Thanks, Maria Elisa Mancuso (EHC Medical Advisory Group Chair), for representing our community at this pivotal moment!”
Apparently, no field is safe from a clash of clans!
The European Haemophilia Consortium eagerly took the stage to brand the ISTH guidelines as “outdated and purposeless” when it comes to acknowledging ”Modern Hemophilia Treatments”.
Maria Elisa Mancuso, Chair of the EHC Medical Advisory Group, and Mark Skinner presented sharply contrasting manuscripts that stirred the debate.
Stay updated on the World of Hemophilia with Hemostasis Today.
-
May 25, 2026, 13:04Mohammad Ameen Ishqair: Blood Group Antigens as Emerging Biomarkers in Disease
-
May 25, 2026, 13:04Dhruvi Joshi: Reduced-Dose DOAC Therapy in Patients With Venous Thromboembolism
-
May 25, 2026, 13:04Luke McLaughlin: Haemophilia Care as a Matter of Global Health Equity
-
May 25, 2026, 12:33Laird Bruce de Graaf: The Most Compassionate Gift You Can Give
-
May 25, 2026, 12:30Dheri Lubis: Deeper Into Immunohematology Beyond Basic Blood Grouping
-
May 25, 2026, 11:20Abdul Mannan: Why Thalassaemia Is More Than Low Haemoglobin
-
May 25, 2026, 11:06Roberta Gualtierotti: Iron Is More Than a Hematologic Parameter
-
May 25, 2026, 11:03Divyaswathi Citla Sridhar: How Bone Health Is Impacted in Bleeding Disorders
-
May 25, 2026, 10:48Ama Ameyaw: Beginning My Research Journey in HIT and Platelet Immunology at the Wen Lab